VEDOLIZUMAB HAS NO EFFECT ON THE COURSE OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RETROSPECTIVE COHORT ANALYSIS

Category Primary study
JournalGastroenterology
Year 2022
This article has no abstract
Epistemonikos ID: b54ac650167146693ca933eb6c19ad351b2f3a6b
First added on: Feb 14, 2025